Walgreens Boots Alliance, Inc. (WBA)
| Market Cap | 15.82B |
| Revenue (ttm) | 144.60B |
| Net Income (ttm) | -6.04B |
| Shares Out | 862.71M |
| EPS (ttm) | -7.00 |
| PE Ratio | n/a |
| Forward PE | 6.27 |
| Dividend | $1.46 (7.96%) |
| Ex-Dividend Date | May 20, 2024 |
| Volume | 5,217,252 |
| Open | 17.98 |
| Previous Close | 17.89 |
| Day's Range | 17.83 - 18.36 |
| 52-Week Range | 17.12 - 32.89 |
| Beta | 0.79 |
| Analysts | Hold |
| Price Target | 26.23 (+43.02%) |
| Earnings Date | Jun 25, 2024 |
About WBA
Walgreens Boots Alliance, Inc. operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise. The International segment offers sale of p... [Read more]
Financial Performance
Financial StatementsAnalyst Forecast
According to 14 analysts, the average rating for WBA stock is "Hold." The 12-month stock price forecast is $26.23, which is an increase of 43.02% from the latest price.
News
Ex-Dividend Reminder: Nuvei, Walgreens And Johnson & Johnson
On 5/20/24, Nuvei, Walgreens Boots Alliance, and Johnson & Johnson will all trade ex-dividend for their respective upcoming dividends. Nuvei will pay its quarterly dividend of $0.10 on 6/6/24, Walgree...
Walgreens launches own brand of opioid overdose reversal drug
U.S. pharmacy chain operator Walgreens Boots Alliance said on Wednesday it has launched its own brand of popular overdose reversal drug, naloxone, which would be available over-the-counter (OTC).
Is Walgreens Stock Undervalued At $18?
Walgreens saw its stock rise 5% on Monday, May 13, following the reports that it has contacted potential buyers for the Boots business. [1] Boots is a UK-based drugstore chain, and it could be valued ...
Walgreens to offer its own cheaper version of opioid overdose reversal drug naloxone
Walgreens said it will sell a two-dose pack of its naloxone for $34.99, around $10 cheaper than over-the-counter Narcan nasal spray.
Walgreens Brand Naloxone Available Online and In Stores This Month
DEERFIELD, Ill.--(BUSINESS WIRE)--Walgreens today announced it is expanding access to an over the counter, life-saving medication with the launch of Walgreens Brand Naloxone HCI Nasal Spray. The produ...
Walgreens Honors Veterans, Active Duty Military and Their Families with Weekend Discount for Memorial Day Friday, May 24 through Monday, May 27
DEERFIELD, Ill.--(BUSINESS WIRE)--To honor the service and sacrifices of Americans who served in the armed forces, Walgreens is offering a Memorial Day weekend discount to all veterans, active-duty mi...
Walgreens Stock Jumps on Report It's Looking To Boot Boots
Walgreens Boots Alliance (WBA) shares jumped in intraday trading Monday following a report that the big drugstore chain has been reaching out to potential buyers of its British-based Boots unit.
Once Again, Walgreens May Try To Sell U.K. Boots Pharmacies
Walgreens Boots Alliance is once again attempting to sell its Boots pharmacies in the United Kingdom as the company chief executive officer Tim Wentworth and his new management team review the company...
Walgreens Stock Is Having Its Best Day in 4 Years. This Is Why.
The pharmacy giant is reaching out to possible buyers of its Boots drugstore chain in the United Kingdom, according to a report.
Walgreens seeks out potential buyers for sale of its UK Boots pharmacy chain, Bloomberg reports
Walgreens Boots Alliance is contacting potential buyers considering a potential sale of its UK-based Boots drugstore chain in a second attempt at separating the unit, Bloomberg News reported on Monday...
Walgreens is reportedly contacting potential Boots buyers
Walgreens Boots Alliance Inc (NASDAQ: WBA) is gaining at writing following a report that it's contacting buyers who may be interested in taking over Boots. What is Boots UK worth?
ADDING MULTIMEDIA Walgreens and Boehringer Ingelheim Are Partnering to Improve Diversity in Clinical Trials
DEERFIELD, Ill. & RIDGEFIELD, Conn.--(BUSINESS WIRE)--Walgreens and Boehringer Ingelheim today announced a strategic collaboration aimed at optimizing recruitment and making clinical trials more acces...
Walgreens and Boehringer Ingelheim Are Partnering to Improve Diversity in Clinical Trials
DEERFIELD, Ill. & RIDGEFIELD, Conn.--(BUSINESS WIRE)--Walgreens and Boehringer Ingelheim today announced a strategic collaboration aimed at optimizing recruitment and making clinical trials more acces...
Walgreens Boots Alliance Provides Summary Notice of Pending and Proposed Settlement of Shareholder Derivative Action
DEERFIELD, Ill.--(BUSINESS WIRE)--Walgreens (Nasdaq: WBA): UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF ILLINOIS EASTERN DIVISION VLADIMIR GUSINSKY REVOCABLE TRUST, Derivatively on Behalf of WA...
Walmart is closing down its health centers. What's that mean for Amazon, Walgreens and CVS?
Walmart Inc. WMT, -0.43% announced Tuesday it's closing its 51 health centers after the retail giant admitted the business had not seen sustainable profits since its inception in 2019.
Walgreens stock price forecast: is it too cheap or a value trap?
Walgreens Boots Alliance (NYSE: WBA) stock price has become a toxic wasteland. It crashed to a low of $17 on Wednesday, much lower than its all-time high of $71.50, a 76% plunge.
As Their Clinics Sputter, Walgreens And Walmart Invest More In Specialty Pharmacy
As Walgreens and Walmart scale back their investments in physician-staffed health clinics, they are forging ahead into the lucrative business of specialty pharmacy.
Walgreens' Next Frontier: Complex Conditions & Cell And Gene Therapy
Walgreens, one of the largest retail pharmacy companies in the world, announced last week that it plans to launch a variety of new services as a part of its newly integrated specialty pharmacy busines...
Walgreens Boots Alliance Declares Quarterly Dividend
DEERFIELD, Ill.--(BUSINESS WIRE)--Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today announced that its board of directors has declared a quarterly dividend of 25 cents per share, unchanged from the p...
Walgreens To Launch $24 Billion Business Dedicated To Specialty Pharmacy
Walgreens is launching Walgreens Specialty Pharmacy, a $24 billion business that integrates new gene and cell services with existing pharmacy assets including the large specialty pharmacy and home del...
Walgreens to help bring cell and gene therapies to patients as it expands specialty pharmacy services
Among the company's investments to "transform" its specialty pharmacy services is the opening of a new facility dedicated to cell and gene therapy services.
Walgreens Launches Gene and Cell Services as Part of Newly Integrated Walgreens Specialty Pharmacy Business
DEERFIELD, Ill.--(BUSINESS WIRE)--Walgreens is expanding its specialty pharmacy services and investing in its capabilities as the company further grows its core pharmacy business to improve patient ou...
DoorDash and Walgreens Launch Unprecedented Access for SNAP Customers
SAN FRANCISCO--(BUSINESS WIRE)--DoorDash (NASDAQ: DASH), the local commerce platform, and Walgreens (NASDAQ: WBA), a trusted, neighborhood health destination serving nearly 10 million customers each d...
Walgreens Encourages Safe Drug Disposal on National Drug Take Back Day Saturday April 27
DEERFIELD, Ill.--(BUSINESS WIRE)--Walgreens is calling on the public to help in the fight against prescription drug abuse by taking part in National Prescription Drug Take Back Day on Saturday, April ...